company score funding investors employees industries biz model city contact
Nouscom HIRING

Viral vector-based cancer vaccines developer.

51
$82M · Series C Bpifrance, 5AM Ventures, Abingworth 1 to 10 Health Tech, Biotech B2C Basel, Switzerland •••••••••••@nouscom.com
Noema Pharma

Clinical-stage central nervous system (CNS) technology.

37
$110M · Series B Sofinnova Partners, Forbion Capital Partners, BioMedPartners 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@noemapharma.com
BioVersys

Novel antiobiotic researcher to fight antimicrobial resistance.

26
$8M · Series C AMR Action Fund 1 to 10 Biotech, Pharma B2B Basel, Switzerland •••••••••••@bioversys.com
KetoSwiss

Clinically tested, patent-protected dietary therapy for migraines.

26
$4M · Seed R42 Group, Healthspan Capital 1 to 10 Health Tech, Foodtech B2C Basel, Switzerland •••••••••••@keto.swiss
Mysthera Therapeutics

Developer of oral therapeutics to treat complex autoimmune diseases.

26
$3M · Seed Forty51 Ventures 1 to 10 Health Tech, Pharma Basel, Switzerland •••••••••••@mystheratx.com
Engimmune Therapeutics

Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.

26
$15M · Seed Novo A/S, Pureos Bioventures 1 to 10 Health Tech, Biotech, Manufacturing B2B Basel, Switzerland •••••••••••@engimmune.com
Scailyte

True precision medicine through single-cell science

26
$1M · Series A Verve Ventures, Swisscom Ventures 11 to 50 Health Tech, AI, Biotech B2B Basel, Switzerland •••••••••••@scailyte.com
Axom

Automated visual inspection for pharma.

21
$877k · Seed Spicehaus Partners 1 to 10 Health Tech Basel, Switzerland •••••••••••@axom.tech
Qnami

Qnami develops quantum sensing technologies designed for nanoscale imaging.

21
$2M · Seed Quantonation, High-Tech Gründerfonds, Verve Ventures 11 to 50 Health Tech, Hardware, Biotech, Navigation and Mapping, Manufacturing B2B Basel, Switzerland •••••••••••@qnami.ch
Vector BioPharma

Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.

20
$30M · Series A 11 to 50 Health Tech, Biotech, Deep Tech B2B Basel, Switzerland •••••••••••@vectorbiopharma.com
Cimeio Therapeutics

Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.

20
$50M · Series A 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Basel, Switzerland •••••••••••@cimeio.com
T3 Pharmaceuticals

T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.

20
$26M · Series C 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Basel, Switzerland •••••••••••@t3pharma.com
Ymmunobio

Preclinical-stage oncology platform.

17
$1M · Seed 1 to 10 Health Tech, Biotech Basel, Switzerland •••••••••••@ymmunobio.com
Lyfa

We are on a mission to make grocery shopping waste-free.

17
$226k · Pre Seed Rockstart 1 to 10 Foodtech, CPG & Consumer Goods, Ecommerce B2C Basel, Switzerland •••••••••••@lyfa.ch
NextImmune

NextImmune is a privately held biotechnology company.

17
$154k · Pre Seed Venture Kick Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@nextimmune.com
Mycamper

MyCamper is a camper sharing platform that opens the camper rental market to private offers.

17
$296k · Pre Seed Wingman Ventures 11 to 50 Travel Tech, Ecommerce B2C, Marketplace Basel, Switzerland •••••••••••@mycamper.ch
Versameb

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

17
$6M · Seed 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@versameb.com
Resistell AG

Antibiotic resistance test.

17
$9M · Series B 1 to 10 Biotech, Deep Tech Basel, Switzerland •••••••••••@resistell.com
Phialogics

Next-gen IgV therapeutics developer.

17
$656k · Pre Seed High-Tech Gründerfonds 1 to 10 Biotech Basel, Switzerland •••••••••••@phialogics.com
MaxWell Biosystems

MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.

14
$4M · Series A 11 to 50 Health Tech, Biotech, Manufacturing B2B Basel, Switzerland •••••••••••@mxwbio.com
Bottneuro

Digital therapies for Alzheimer's disease.

14
$4M · Seed 11 to 50 Health Tech Basel, Switzerland •••••••••••@bottneuro.ch
AERA Health

Preventive health technology.

14
$4M · Pre Seed 11 to 50 Health Tech, Biotech Basel, Switzerland •••••••••••@aera.health
Lyfegen

Pioneering value & data-driven healthcare for patients

10
$991k · Seed 11 to 50 Health Tech, Insuretech, Enterprise Software B2B, SaaS Basel, Switzerland •••••••••••@lyfegen.com
Nutrix

Reshaping the future of healthcare

10
$258k · Pre Seed 1 to 10 Health Tech, Business Intelligence B2B, SaaS Basel, Switzerland •••••••••••@nutrix.tech
Caresocius

Caresocius is a community-based online platform for seconde opinion, booking health services and manage travel logistics around the world.

10
$500k · Seed 1 to 10 Health Tech B2B, SaaS Basel, Switzerland •••••••••••@caresocius.org
Syndata

syndata works on the statistics and indicators of the doctors thereby analyzing the rising costs in healthcare.

10
$211k · Pre Seed 1 to 10 Health Tech, Data and Analytics, Business Intelligence, Developer Tools B2B, SaaS Basel, Switzerland •••••••••••@syndata.ch
Cellestia

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.

7
N/A 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Basel, Switzerland •••••••••••@cellestia.com
Mysthera Therapeutics

Developer of oral therapeutics to treat complex autoimmune diseases.

4
N/A 1 to 10 Health Tech, Pharma Basel, Switzerland •••••••••••@
OTHER CITIES
OTHER CITIES IN Switzerland